Historical control

OTHER5 trials

Sponsors

Barretos Cancer Hospital, Richard Bedlack, M.D., Ph.D., Boston Medical Center, Fu Jen Catholic University, The University of Texas Health Science Center, Houston

Conditions

ALS (Amyotrophic Lateral Sclerosis)Adherence, MedicationAortic AneurysmCOVID-19 Testing BehaviorsRadiation InjuriesRectal BleedingTelangiectasis

Phase 2

Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.

CompletedNCT02104271

Barretos Cancer HospitalRadiation Injuries, Rectal Bleeding, Telangiectasis

Start: 2013-01-31End: 2015-08-31Updated: 2015-08-27

ALS Reversals - Lunasin Regimen

CompletedNCT02709330

Richard Bedlack, M.D., Ph.D.ALS (Amyotrophic Lateral Sclerosis)

Start: 2016-04-30End: 2017-09-13Updated: 2018-12-13

Unknown Phase

Pharmacist-led Intervention on Adherence in Patients Undergoing Treatment With an Oral Oncology Medication

CompletedNCT03104114

Boston Medical CenterAdherence, Medication

Start: 2017-05-02End: 2019-02-15Updated: 2019-08-01

Utilizing 3D Printed Personalized Aortic Lesion Models in Preoperative Assessment

RecruitingNCT06147024

Fu Jen Catholic UniversityAortic Aneurysm

Start: 2024-04-08End: 2027-07-31Target: 10Updated: 2026-02-27

Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing

CompletedNCT07074171

The University of Texas Health Science Center, HoustonCOVID-19 Testing Behaviors

Start: 2023-04-03End: 2024-12-12Updated: 2026-01-06

Related Papers

Lunasin does not slow ALS progression: results of an open-label, single-center, hybrid-virtual 12-month trial

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2019-01-2137 citations